Company: OnKure Inc.
Job title: Professor, Department of Biochemistry, University of Colorado-Boulder and Co-Founder and SAB
Panel Discussion – HDAC3, BET, RNA, So Many Targets – Exploring New Potential in Well Known Targets to Create New Value & Diversify Pipelines 9:30 am
Discuss disease positioning and the importance of this in creating value out of your existing IP Highlight the criteria you should consider before exploring a new therapeutic area Explore current examples of therapeutics that have been reused in this way How can this potential be capitalized on for both oncological and non-oncological indications? Dr. NikhilRead more
day: Day One